Literature DB >> 22075589

Clostridium difficile mixed infection and reinfection.

David W Eyre1, A Sarah Walker, David Griffiths, Mark H Wilcox, David H Wyllie, Kate E Dingle, Derrick W Crook, Tim E A Peto.   

Abstract

Isolates from consecutive Clostridium difficile infection (CDI) fecal samples underwent multilocus sequence typing. Potential reinfections with different genotypes were identified in 88/560 (16%) sample pairs taken 1 to 1,414 days (median, 24; interquartile range [IQR], 1 to 52 days) apart; odds of reinfection increased by 58% for every doubling of time between samples. Of 109 sample pairs taken on the same day, 3 (3%) had different genotypes. Considering samples 0 to 7 days apart as the same CDI, 7% of cases had mixed infections with >1 genotype.

Entities:  

Mesh：

Year:  2011        PMID： 22075589      PMCID： PMC3256686          DOI： 10.1128/JCM.05177-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Recurrence in tuberculosis: relapse or reinfection?

Authors:  Marie-Laurence Lambert; Epco Hasker; Armand Van Deun; Dominique Roberfroid; Marleen Boelaert; Patrick Van der Stuyft
Journal:  Lancet Infect Dis       Date:  2003-05       Impact factor: 25.071

3.  Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

Authors:  S Johnson; A Adelmann; C R Clabots; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

4.  Defining criteria to interpret multilocus variable-number tandem repeat analysis to aid Clostridium difficile outbreak investigation.

Authors:  George Broukhanski; Andrew Simor; Dylan R Pillai
Journal:  J Med Microbiol       Date:  2011-04-07       Impact factor: 2.472

5.  Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

Authors:  M H Wilcox; W N Fawley; C D Settle; A Davidson
Journal:  J Hosp Infect       Date:  1998-02       Impact factor: 3.926

6.  Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.

Authors:  Danielle Wroblewski; George E Hannett; Dianna J Bopp; Ghinwa K Dumyati; Tanya A Halse; Nellie B Dumas; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

7.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

8.  Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens.

Authors:  Hannah E Tanner; Katherine J Hardy; Peter M Hawkey
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

9.  Multilocus sequence typing of Clostridium difficile.

Authors:  David Griffiths; Warren Fawley; Melina Kachrimanidou; Rory Bowden; Derrick W Crook; Rowena Fung; Tanya Golubchik; Rosalind M Harding; Katie J M Jeffery; Keith A Jolley; Richard Kirton; Tim E Peto; Gareth Rees; Nicole Stoesser; Alison Vaughan; A Sarah Walker; Bernadette C Young; Mark Wilcox; Kate E Dingle
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

10.  Clinical Clostridium difficile: clonality and pathogenicity locus diversity.

Authors:  Kate E Dingle; David Griffiths; Xavier Didelot; Jessica Evans; Alison Vaughan; Melina Kachrimanidou; Nicole Stoesser; Keith A Jolley; Tanya Golubchik; Rosalind M Harding; Tim E Peto; Warren Fawley; A Sarah Walker; Mark Wilcox; Derrick W Crook
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240
View more
  28 in total

1.  Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.

Authors:  Stuart Johnson; Dale N Gerding; Thomas J Louie; Nancy M Ruiz; Sherwood L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

2.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

3.  Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.

Authors:  Megan K Shaughnessy; Aleh Bobr; Michael A Kuskowski; Brian D Johnston; Michael J Sadowsky; Alexander Khoruts; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

4.  Association of relapse of Clostridium difficile disease with BI/NAP1/027.

Authors:  Jane W Marsh; Rangolee Arora; Jessica L Schlackman; Kathleen A Shutt; Scott R Curry; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

5.  Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort.

Authors:  Aakash Balaji; Egon A Ozer; Larry K Kociolek
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

6.  Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin.

Authors:  Pamela R Fry; Siddhartha Thakur; Melanie Abley; Wondwossen A Gebreyes
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

7.  Role of Coinfecting Strains in Recurrent Clostridium difficile Infection.

Authors:  Janet Sun; Tracy Mc Millen; N Esther Babady; Mini Kamboj
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

8.  Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.

Authors:  Adam A Behroozian; Jeffrey P Chludzinski; Eugene S Lo; Sarah A Ewing; Sheila Waslawski; Duane W Newton; Vincent B Young; David M Aronoff; Seth T Walk
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-12       Impact factor: 3.254

9.  The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study.

Authors:  J Islam; A L Taylor; K Rao; G Huffnagle; V B Young; C Rajkumar; J Cohen; P Papatheodorou; D M Aronoff; M J Llewelyn
Journal:  Anaerobe       Date:  2014-04-05       Impact factor: 3.331

10.  Diverse sources of C. difficile infection identified on whole-genome sequencing.

Authors:  Derrick W Crook; Mark H Wilcox; Tim E A Peto; A Sarah Walker; David W Eyre; Madeleine L Cule; Daniel J Wilson; David Griffiths; Alison Vaughan; Lily O'Connor; Camilla L C Ip; Tanya Golubchik; Elizabeth M Batty; John M Finney; David H Wyllie; Xavier Didelot; Paolo Piazza; Rory Bowden; Kate E Dingle; Rosalind M Harding
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.